Related Experiment Videos
Survival analysis using auxiliary variables via multiple imputation, with application to AIDS clinical trial data
Cheryl L Faucett1, Nathaniel Schenker, Jeremy M G Taylor
1Department of Biostatistics, UCLA School of Public Health, Los Angeles, California 90095-1772, USA.
Biometrics
|March 15, 2002
Summary
This study introduces a multiple imputation method using auxiliary variables to improve survival analysis with censored data. The approach enhances efficiency and corrects for dependent censoring in AIDS clinical trials.
Area of Science:
- Biostatistics
- Epidemiology
- Clinical Trials
Background:
- Censored observations in survival analysis limit data utility.
- Auxiliary variables can potentially recover information from censored data.
- Accurate statistical methods are crucial for analyzing clinical trial outcomes.
Purpose of the Study:
- To develop and evaluate a multiple imputation approach for utilizing auxiliary variables in survival analysis.
- To apply this method to AIDS clinical trial data using CD4 counts as a time-dependent auxiliary variable.
- To assess the impact of this imputation technique on treatment effect estimation and statistical efficiency.
Main Methods:
- Developed a joint model incorporating a hierarchical change-point model for CD4 counts and a time-dependent proportional hazards model for AIDS events.
- Employed Markov chain Monte Carlo (MCMC) methods for multiple imputation of event times for censored observations.
- Combined results from imputed datasets using standard multiple imputation techniques.
Main Results:
- Multiple imputation resulted in minor changes to the estimated effect of Zidovudine (ZDV) but yielded smaller standard errors compared to analyzing observed data alone.
- Sensitivity analyses confirmed the robustness of qualitative findings across various imputation models.
- Simulation studies indicated improved efficiency and partial correction for dependent censoring.
Conclusions:
- The proposed multiple imputation method effectively utilizes auxiliary variables to enhance survival analysis with censored data.
- The approach offers improved statistical efficiency and robustness in clinical trial settings.
- Further research is needed to address the compatibility between the primary analysis and the imputation model.